Evaluation of training strategies for U-net-based cervical cancer CBCT segmentation in a multi-institutional setting
Physics and Imaging in Radiation Oncology · 2026-11 · 101128
DOI: 10.1016/j.phro.2026.101128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics and Imaging in Radiation Oncology, 2026-11. Verfasst von Songyue Han und 15 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National League Against Cancer, French National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National League Against Cancer
- French National Cancer Institute
Zitieren
APA
Han, S., Lebret, D., Lafond, C., Leseur, J., Hemon, C., Barateau, A., Nunes, J., Peignaux, K., Mesgouez-Nebout, N., Blanc-Onfroy, M. L., Hanzen, C., Allouache, N., Renard-Oldrini, S., Tinier, F. L., Crevoisier, R. D., & Simon, A. (2026). Evaluation of training strategies for U-net-based cervical cancer CBCT segmentation in a multi-institutional setting. Physics and Imaging in Radiation Oncology, 101128. https://doi.org/10.1016/j.phro.2026.101128
Vancouver
Han S, Lebret D, Lafond C, Leseur J, Hemon C, Barateau A, et al. Evaluation of training strategies for U-net-based cervical cancer CBCT segmentation in a multi-institutional setting. Physics and Imaging in Radiation Oncology. 2026:101128. doi:10.1016/j.phro.2026.101128
BibTeX
@article{Han2026,
author = {Han, Songyue and Lebret, Delphine and Lafond, Caroline and Leseur, Julie and Hemon, Cedric and Barateau, Anaïs and Nunes, Jean-Claude and Peignaux, Karine and Mesgouez-Nebout, Nathalie and Blanc-Onfroy, Magali Le and Hanzen, Chantal and Allouache, Nedjla and Renard-Oldrini, Sophie and Tinier, Florence Le and Crevoisier, Renaud de and Simon, Antoine},
title = {Evaluation of training strategies for U-net-based cervical cancer CBCT segmentation in a multi-institutional setting},
journal = {Physics and Imaging in Radiation Oncology},
year = {2026},
pages = {101128},
doi = {10.1016/j.phro.2026.101128}
}
EUVIMED